Study finds prescription drug prices can vary by thousands of dollars
According to a new report by the U.S. Public Interest Research Group, the price of the same prescription drug can
Read More
Part D/Prescription Drugs
If Purdue Pharma declares bankruptcy, what would it mean for lawsuits against the opioid manufacturer?
(By Andrew Joseph for STAT) The legal battle over who’s at fault for the opioid crisis, which involves more than
Read MoreLilly will sell a version of its popular insulin at half the price, but will this appease critics?
(By Ed Silverman for STAT) As drug makers come under increasing pressure to lower prices, Eli Lilly (LLY) is trying
Read MoreDon’t delay if you plan on switching your Medicare Advantage plan
You have until March 31t to drop the Medicare Advantage pan you are not satisfied with and switch over to
Read MoreBig Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes
(By Sydney Lupkin and Elizabeth Lucas and Victoria Knight for Kaiser Health News) Dozens of patient advocacy groups, like the
Read MoreStates, eager to lower drug prices, regroup after courts strike down Maryland ‘price-gouging’ law
(By Lev Facher for STAT) WASHINGTON — A legal setback in Maryland has state legislatures across the country re-examining their
Read MoreAmericans Ready To Crack Down On Drug Prices That Force Some To Skip Doses
(By Jay Hancock for Kaiser Health News) Large majorities of Americans from both major parties support steps to control prescription
Read MoreSenate’s drug price hearing: 6 takeaways
(By Alia Paavola for Becker’s Hospital Review) Seven pharmaceutical executives, representing $140 billion in U.S. revenue, testified before the Senate Finance Committee
Read MoreJustice Department calls for final approval in CVS-Aetna merger
(By Morgan Haefner for Becker’s Hospital Review) The Department of Justice formally requested a judge sign off on its settlement
Read MorePharma Execs Dig In For A Fight Against Outraged Senators
(By Emmarie Huetteman and Jay Hancock for Kaiser Health News) Senators got their first opportunity Tuesday to prod drugmakers about
Read More